Canan Dirican

MD, Researcher | Incoming chief resident at NYMC | Nelson Lab @fredhutch | Interested in hematology/oncology

[Canan Dirican @CananDirican]

Our new study is now published in @JCOOP_ASCO.
Full text 👉 https://t.co/MZRDX2bAvE
Here’s what we found ⬇️

[Canan Dirican @CananDirican]

@vendy1299 @ASCO @OncMedEdCoP @ASCOTECAG @ASCOPost @IMG_Oncologists @hemeoncfellow @oncodaily @OncLive Congrats Vedant, very well deserved!! 👏🏻

[Canan Dirican @CananDirican]

Had a wonderful time at #ASCO26 as a trainee.
Thank you @NazliDizman and the @ASCOTECAG team for creating welcoming spaces, mentorship opportunities and trainee-focused programming for residents, fellows and early-career oncologists.

[Canan Dirican @CananDirican]

@AbiSivaMD Thank you, Dr. Siva! It was a pleasure meeting you as well. I really appreciated your talk and the insights you shared with the IMG community.

[Canan Dirican @CananDirican]

Still reflecting on an inspiring #ASCO26 session for IMG oncologists.

“Where you start does not define where you can go” was a powerful message from Dr. @AbiSivaMD and a reminder of the importance of mentorship and community in building a career in oncology as an IMG.

#IMGoncCoP @IMG_Oncologists

[Canan Dirican @CananDirican]

Great insights from The Oncology Forum GU panel at #ASCO26! Practical discussion translating key GU oncology updates into real-world practice.

Thank you @PGrivasMDPhD @CParkMD @katy_beckermann for an excellent session!

[Canan Dirican @CananDirican]

@Aish_Rmsh @ASCO @ASCOTECAG Congrats Aishwarya!!

[Canan Dirican @CananDirican]

Wow 🔥 Fantastic evening at the Advancements in Oncology session by @OncBrothers in #ASCO26! Insightful discussions on the latest advances across lung, GU, breast and GI oncology.

Grateful for the opportunity to learn from leaders in the field and connect with the oncology community!

[Canan Dirican @CananDirican]

@JiazhangXing Congrats Jia!!

[Nazli Dizman @NazliDizman]

Okay, trainees @ASCO #ASCO26, here is the plan! Badge/bag pickup, then straight to next door: your "home base", the @ASCOTECAG Lounge. Please come say hi!
🔗 Lots of networking starting with @ASCO-SEP trivia at 2.30 pm today!
🤩1:1 mentoring, panels, round table discussions all tailored to the needs of trainees and early career
☕️ Breakfast, snacks and barista coffee
🛋️ Lots of plugs to charge your devices, and comfy couches to recharge yourselves

@OncoAlert @montypal @IMG_Oncologists @DrChoueiri @jrgralow @COlazagasti @FionnualaCrowle @ja_ocejo @noha_soror @royaryam @OncoAlert @urotoday @PCF_Science @BladderCancerUS @kidneycan @KidneyCancer @Uromigos @DrKarineTawagi @OncBrothers @crisbergerot @PauloBergerot @realbowtiedoc @DVAraujoMD @DrBarbiOnc @LauraEsfeller @FunchainMD @YGaritaonaindia @jgong15 @DrSAHaddad @GIMedOnc @iandresmeraz @SakditadMD @RamilaShilpakar @RohitBanwar @lungoncdoc

[IMG Oncologists @IMG_Oncologists]

🚨Save the date🚨
@ASCO #IMG Community of Practice Meeting at #ASCO26
⏰May 29, 1-2:30 PM CST
📌Room E253ab, McCormick Place
Join us to discuss barriers & opportunities for #IMGs
ASCO IMG CoP👉https://t.co/ke4h9obYok
@ASCOPost #IMGoncCoP #MedEd #MedTwitter @ASCOTECAG

[Canan Dirican @CananDirican]

Honored and grateful to serve as Chief Resident for the 2026-2027 academic year at New York Medical College.

Looking forward to learning alongside an incredible group of colleagues while supporting our residents, education, and patient care in the year ahead.

[Canan Dirican @CananDirican]

@montypal @GUOncologyNow @nymedcollege Thank you so much for your support Dr. Pal, I really appreciate it!

[GU Oncology Now @GUOncologyNow]

🔎 @CananDirican of @nymedcollege discusses her research evaluating rural disparities in access to #urology and radiation services for patients with localized #prostate cancer, with a focus on distinguishing appropriate active surveillance from potential undertreatment: https://t.co/DLMDez2sPG

[Canan Dirican @CananDirican]

Excited to share a series of interviews on our work examining rural disparities in management of GU cancers.

Across disease sites, geography continues to shape access to guideline-concordant care.

Grateful to discuss this work with @GUOncologyNow

🔗 Prostate: https://t.co/v7YjGmnnMd
🔗 Kidney: https://t.co/cUh4PzhIkM
🔗 Testicular: https://t.co/hfRSs8Fjzt

[Canan Dirican @CananDirican]

Excited to share our study on rural-urban disparities in early-stage GU cancer management, now published online in @UrolOncol.

Using SEER data, we found persistent geographic differences in surgical approach for kidney cancer and receipt of definitive therapy for prostate cancer, despite clear NCCN guidelines.

https://t.co/S9tf3PCkqE

#MedTwitter #Oncology #UroOnc #HealthEquity

[Canan Dirican @CananDirican]

Grateful to contribute to projects presented at #NCCN2026 alongside colleagues, spanning outcomes research and immunotherapy.

Really value the opportunity to collaborate across different areas of oncology and to learn from this team.

[Canan Dirican @CananDirican]

Excited to present our work on rural disparities in the management of cT1a renal masses at #NCCN2026

Among surgically managed patients, guideline-concordant nephron-sparing care remains unevenly accessible.

Grateful for the mentorship and collaboration that made this possible.

#MedTwitter #HemeOnc #UroOnc #HealthDisparities